Across TCGA pan-cancer cohorts, PABPC1P7 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated PABPC1P7 data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher PABPC1P7 RNA is associated with better overall survival. In most high-consensus cancer types, elevated PABPC1P7 expression acts as an unfavorable survival marker, although some lineages such as KIRP and PAAD show a favorable association.
KIRP, PAAD, and HNSC are the cancer types where PABPC1P7 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.